CIBC Private Wealth Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $105M | Sell |
1,096,053
-291,633
| -21% | -$28.6M | 0.18% | 123 |
|
|
2025
Q3 | $135M | Buy |
1,387,686
+9,670
| +0.7% | +$1M | 0.23% | 110 |
|
|
2025
Q2 | $148M | Buy |
1,378,016
+187,205
| +16% | +$18.9M | 0.26% | 98 |
|
|
2025
Q1 | $108M | Buy |
1,190,811
+1,172,866
| +6,536% | +$118M | 0.23% | 103 |
|
|
2024
Q4 | $1.72M | Sell |
17,945
-89
| -0.5% | -$7.83K | ﹤0.01% | 600 |
|
|
2024
Q3 | $1.51M | Buy |
18,034
+2,818
| +19% | +$222K | ﹤0.01% | 614 |
|
|
2024
Q2 | $1.16M | Buy |
15,216
+530
| +4% | +$38.8K | ﹤0.01% | 630 |
|
|
2024
Q1 | $1M | Sell |
14,686
-137
| -0.9% | -$8.81K | ﹤0.01% | 678 |
|
|
2023
Q4 | $857K | Sell |
14,823
-12,854
| -46% | -$686K | ﹤0.01% | 666 |
|
|
2023
Q3 | $1.46M | Buy |
27,677
+5,363
| +24% | +$281K | ﹤0.01% | 544 |
|
|
2023
Q2 | $1.21M | Sell |
22,314
-7,604
| -25% | -$397K | ﹤0.01% | 568 |
|
|
2023
Q1 | $1.5M | Sell |
29,918
-3,951
| -12% | -$186K | ﹤0.01% | 557 |
|
|
2022
Q4 | $1.36M | Buy |
33,869
+1,480
| +5% | +$64.1K | ﹤0.01% | 476 |
|
|
2022
Q3 | $1.25M | Buy |
32,389
+1,457
| +5% | +$58.4K | ﹤0.01% | 551 |
|
|
2022
Q2 | $1.15M | Sell |
30,932
-3,545
| -10% | -$144K | ﹤0.01% | 575 |
|
|
2022
Q1 | $1.53M | Buy |
34,477
+4,500
| +15% | +$195K | ﹤0.01% | 568 |
|
|
2021
Q4 | $1.27M | Sell |
29,977
-592
| -2% | -$24.9K | ﹤0.01% | 609 |
|
|
2021
Q3 | $1.33M | Buy |
30,569
+2,969
| +11% | +$131K | ﹤0.01% | 567 |
|
|
2021
Q2 | $1.18M | Buy |
27,600
+1,456
| +6% | +$61.3K | ﹤0.01% | 629 |
|
|
2021
Q1 | $1.01M | Buy |
26,144
+4,039
| +18% | +$153K | ﹤0.01% | 666 |
|
|
2020
Q4 | $795K | Sell |
22,105
-4,186
| -16% | -$151K | ﹤0.01% | 678 |
|
|
2020
Q3 | $1M | Buy |
26,291
+5,813
| +28% | +$224K | ﹤0.01% | 553 |
|
|
2020
Q2 | $719K | Sell |
20,478
-10,609
| -34% | -$382K | ﹤0.01% | 497 |
|
|
2020
Q1 | $1.01M | Buy |
31,087
+3,481
| +13% | +$136K | ﹤0.01% | 507 |
|
|
2019
Q4 | $1.25M | Buy |
27,606
+10,092
| +58% | +$422K | ﹤0.01% | 543 |
|
|
2019
Q3 | $712K | Buy |
17,514
+10,755
| +159% | +$456K | ﹤0.01% | 627 |
|
|
2019
Q2 | $291K | Sell |
6,759
-587
| -8% | -$22.6K | ﹤0.01% | 823 |
|
|
2019
Q1 | $282K | Sell |
7,346
-186
| -2% | -$7.1K | ﹤0.01% | 832 |
|
|
2018
Q4 | $266K | Buy |
7,532
+1,320
| +21% | +$47.9K | ﹤0.01% | 787 |
|
|
2018
Q3 | $239K | Buy |
6,212
+1,286
| +26% | +$44.9K | ﹤0.01% | 896 |
|
|
2018
Q2 | $161K | Buy |
4,926
+28
| +0.6% | +$844 | ﹤0.01% | 954 |
|
|
2018
Q1 | $134K | Buy |
4,898
+15
| +0.3% | +$408 | ﹤0.01% | 978 |
|
|
2017
Q4 | $121K | Buy |
+4,883
| New | +$135K | ﹤0.01% | 1002 |
|
Other funds holding BSX
CIBC Private Wealth Group's BSX Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its Boston Scientific (BSX) stake by 21% in Q4 2025, selling an estimated $28.6M and leaving 1,096,053 shares worth $105M. The position accounts for 0.18% of the portfolio, ranked #123.
CIBC Private Wealth Group first reported a position in BSX in Q4 2017 and has held it in 33 quarters since. The position peaked at $148M in Q2 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.
- CIBC Private Wealth Group held 1,096,053 shares of Boston Scientific worth $105M as of Q4 2025.
- CIBC Private Wealth Group sold 291,633 Boston Scientific shares in Q4 2025, an estimated $28.6M.
- Boston Scientific made up 0.18% of CIBC Private Wealth Group's portfolio in Q4 2025, its #123 holding.
- CIBC Private Wealth Group first reported a position in Boston Scientific in Q4 2017 and has held it in 33 quarters since.
- CIBC Private Wealth Group's Boston Scientific position peaked at $148M in Q2 2025.
- 1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.